2010
DOI: 10.1523/jneurosci.1405-10.2010
|View full text |Cite
|
Sign up to set email alerts
|

The BDNF Val66Met Polymorphism Impairs NMDA Receptor-Dependent Synaptic Plasticity in the Hippocampus

Abstract: The Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene results in a defect in regulated release of BDNF and affects episodic memory and affective behaviors. However, the precise role of the BDNF Val66Met polymorphism in hippocampal synaptic transmission and plasticity has not yet been studied. Therefore, we examined synaptic properties in the hippocampal CA3-CA1 synapses of BDNF Met/Met mice and matched wild-type mice. Although basal glutamatergic neurotransmission was normal, both youn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
134
1

Year Published

2011
2011
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 163 publications
(146 citation statements)
references
References 42 publications
10
134
1
Order By: Relevance
“…In agreement with these findings, LTP is significantly inhibited when highfrequency stimulation (HFS) is performed in the presence of the BDNF and NT4 (neurotrophin-4) scavenger TrkB-IgG or with antiTrkB antibodies (Chen et al, 1999;Figurov et al, 1996;Kang et al, 1997;Korte et al, 1998). The Val66Met polymorphism in the Bdnf gene which results in a defect in regulated release of BDNF and affects episodic memory (Egan et al, 2003) also leads to an impairment of LTP (Ninan et al, 2010), further indicating a role for BDNF in this form of plasticity in the hippocampus. However, at this point the timing and relative role of the pre-and post-synaptic region in the release of BDNF still remains to be elucidated.…”
Section: Bdnf and Ltp In The Hippocampusmentioning
confidence: 65%
“…In agreement with these findings, LTP is significantly inhibited when highfrequency stimulation (HFS) is performed in the presence of the BDNF and NT4 (neurotrophin-4) scavenger TrkB-IgG or with antiTrkB antibodies (Chen et al, 1999;Figurov et al, 1996;Kang et al, 1997;Korte et al, 1998). The Val66Met polymorphism in the Bdnf gene which results in a defect in regulated release of BDNF and affects episodic memory (Egan et al, 2003) also leads to an impairment of LTP (Ninan et al, 2010), further indicating a role for BDNF in this form of plasticity in the hippocampus. However, at this point the timing and relative role of the pre-and post-synaptic region in the release of BDNF still remains to be elucidated.…”
Section: Bdnf and Ltp In The Hippocampusmentioning
confidence: 65%
“…We have recently described significant effects of this SNP on synaptic transmission and plasticity at the CA3-CA1 synapse (Ninan et al, 2010). To our knowledge, these are the first studies to identify impairments in synaptic plasticity resulting from the BDNF Val66Met SNP in the DG.…”
Section: Discussionmentioning
confidence: 84%
“…These results suggest that fluoxetine affects plasticity by mechanisms other than neurogenesis. The lack of effect of fluoxetine on BDNF levels or a potential alteration of synaptic function might be responsible for fluoxetine-resistant LTP impairment in BDNF Met/Met mice (Colino and Malenka, 1993;Ninan et al, 2010). BDNF has reliably been shown to be a significant promoter of synaptic excitability and LTP within the hippocampus (Minichiello, 2009) and the loss of TrkB from newborn neurons in this region significantly impact LTP (Bergami et al, 2008).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…BDNF is active in the hippocampus and cortex where it regulates neuronal excitability, synaptic plasticity, long-term potentiation (LTP), and neurogenesis (Acheson et al 1995;Huang & Reichardt 2001;Ninan et al 2010). BDNF is known to bind the tyrosine kinase receptor B (TrkB) receptor, modulating neurotransmitter receptors to activate various kinase signaling pathways of phosphoinositide 3-kinase/AKT (PI3K/AKT), extracellular signal-regulated kinases (ERK1/ 2), mitogen-activated protein kinase (MAPK), or calcium/ calmodulin dependent protein kinase (CaMKII), and inducing phospho-CREB-mediated transcription (Mai et al 2002;Garoflos et al 2005;Luikart et al 2008).…”
Section: Introductionmentioning
confidence: 99%